缓释/控释制剂的风险管理

风险管理对于缓释/控释制剂的用药安全十分重要。本文通过统计《中国药典》2010年版二部收载的缓释/控释制剂品种、规格、剂型和服用方法 ,并结合文献分析缓控/释制剂存在的风险,探讨造成此类制剂风险的原因,并为构建风险管理体系提出相应建议。建议提高缓释/控释制剂注册审批的技术要求,严格控制生产工艺及质量监测,发挥药师的药学服务作用,提高医生和患者对于缓释/控释制剂的认识。     

药学类高校构建药学多学科综合性实验的探索

药学实验对于培养高素质的药学人才起着至关重要的作用，本校开展了药学多学科综合性实验，将药学相关的二级学科实验进行有机地结合，提高了本科生对药学专业多学科知识的理解和综合运用能力。     

Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit

We herein describe an inter-specialists unit for the monitoring and management of biological therapies and analyze the utilization of biological agents across specialties and diseases. Protocols and therapeutic objectives, as well as outcomes and protocol deviations, are shared and discussed periodically between specialists. All patients treated at one centre with any biological treatment from January 2000 by rheumatology, gastroenterology, dermatology, or neurology, regardless diagnosis, are identified by Clinical Pharmacy and included in an ongoing database that detects use and outcome. The drugs, survival, and reasons for discontinuation differ significantly across specialties. This approach has helped us recognizing the challenges and size of the problem of sharing expensive medications across specialties, and has served as a starting point to contribute to the better use of these compounds.     

FIP Perspectives: Realising global patient safety goals requires an integrated approach with pharmacy at the core

Patient safety is becoming increasingly recognised as a top priority for action that requires a collective and coordinated response. The leading cause of harm or injury in health care systems is medication errors. As medicines experts, the pharmacy workforce plays a key role in minimising medication errors and mitigating the global challenge of patient safety. Pharmacists’ involvement in ensuring patient safety is crucial. Pharmacists are charged with the responsibility to ensure that when a patient receives and uses a medicine, it will not cause harm or death. The International Pharmaceutical Federation (FIP) recognises the critical role the pharmacy plays in realising global, regional and national patient safety goals; and works with its partners, stakeholders and members around the world to advocate for the role of pharmacy in achieving this global patient safety agenda and to envision a world of safe access to medicines and care.     

浅谈药学专业人体解剖生理学的教学体会和教学方法

人体解剖生理学是一门重要的基础课程，在针对药学专业学生的教学过程中存在着一些问题，课时数相对较少，教师教学方法和思维刻板保守，缺乏药学专业知识基础，学生对本课程重视度不够，缺乏足够的学习兴趣。针对这些实际问题，要求教师结合药学专业的学科特点来讲授人体解剖生理学知识，寻找新的教学方法，以提高学生的知识理解能力，培养学生的创新思维和主动学习的意识。     

基层医院药学工作的几点思考

目的通过对当前基层医院药学工作开展现状的分析,提出几点建议和思考。方法通过对基层医院实地考察,结合药学工作有关文献资料,思考当前基础医院药学工作存在的问题与发展策略。结果现阶段社会对药学工作提出了更高的要求,但基层医院药学工作开展中仍然存在着基层医院对药学工作重要性的认识相对滞后、药学人才结构不合理、药师知识结构不尽合理、临床药学配套政策不完善等问题,必须针对这些问题找出相应的对策。结论提高基层医院药学工作水平势在必行,医院领导要重视药学工作,国家应出台配套法规,药师要不断提高自身素质,各方共同推进基层医院药学工作的转型。     

Implementing FIP's global pharmaceutical education transformation vision in Sub-Saharan African Countries

The realization of a competent, versatile and adaptable Pharmaceutical workforce which is a key component in achieving the World Health Organization Universal Health Coverage agenda in 2030 depends on the supply of adequately trained pharmacy workforce who can improve access to quality medicines while delivering quality pharmaceutical services. Despite the rise in the density of pharmacists across all World Health Organization regions, African countries still stay considerably behind in terms of absolute capacity per capita which means that the pharmacy workforce in Africa continues to be very low and not adequate to deliver the pharmaceutical services needs of the region. The International Pharmaceutical Federation is leading the transformation of pharmacy education in Sub-Saharan African countries to bridge this gap with a spotlight on increasing academic capacity, establishing needs-based education strategies and creating an enabling practice environment through advocacy. This commentary paper seeks to discuss the strategies such as the FIP-UNITWIN Programme and the Kenya-Nottingham Partnership utilized in transforming the pharmacy education and therefore the pharmaceutical workforce within the Sub-Saharan African Countries. This paper also gives a clue on subsequent steps which can advance pharmaceutical practice and science in the region.     

An ethics-based approach to global health research part 4: Scholarship and publications

Disseminating research findings from global health collaborations is essential to advancing science. However, there are a number of ethical considerations and potential challenges to address to ensure thoughtful and non-exploitative reporting. The factors include the benefits and risks to publication, authorship criteria or values, and the accessibility of forums or journals in which to pursue publication. This paper provides commentary related to planning for writing, communicating intentions to publish, obtaining permissions to publish, risks in internationally collaborative work, authorship principles, and journal selection. Authors' and editors’ knowledge of experienced individuals from both pharmacy literature, medical fields, and general publications is incorporated to provide an assessment of risks and benefits of publication of international global health research.